Spots Global Cancer Trial Database for anal cancer
Every month we try and update this database with for anal cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2). | NCT04472429 | Squamous Cell C... | carboplatin paclitaxel retifanlimab | 18 Years - | Incyte Corporation | |
| Interleukin-12 in Treating Patients With Cancer in the Abdomen | NCT00003046 | Anal Cancer Colorectal Canc... Gallbladder Can... Gastric Cancer Pancreatic Canc... | Recombinant Int... | 18 Years - | M.D. Anderson Cancer Center | |
| Radiation Dosimetry Study Comparing 2 Different Patient Setups in Anal/Rectal Cancer Patients | NCT00693173 | Anal Cancer | 18 Years - 80 Years | The University of Texas Medical Branch, Galveston | ||
| Multimodal Monitoring of Radiotherapy Response in Squamous Cell Cancer | NCT02379039 | Squamous Carcin... Head and Neck C... Anal Cancer Lung Cancer Esophageal Canc... Cervix Cancer | 18 Years - | Umeå University | ||
| Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer | NCT00903396 | Anal Cancer Carcinoma of th... Colorectal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Gastrointestina... Liver Cancer Nausea and Vomi... Pancreatic Canc... Primary Periton... Small Intestine... | palonosetron hy... placebo | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Intrafractional Vaginal Dilation in Anal Cancer Patients Undergoing Pelvic Radiotherapy | NCT04094454 | Anal Cancer | special tampon ... standard tampon... | 18 Years - | University Hospital Heidelberg | |
| A Message Framing Intervention for Increasing Parental Acceptance of Human Papillomavirus Vaccination | NCT03856437 | Cervical Cancer Anal Cancer Penile Cancer | HPV vaccination... | 18 Years - 99 Years | University of Maryland, College Park | |
| HPV-SAVE_Merck_Sub-Study for Preventing Recurrence of HSIL | NCT03947775 | Anal Intraepith... Anal Cancer Human Papilloma... | 9-valent HPV va... | 18 Years - | University Health Network, Toronto | |
| Re-optimization Based Online Adaptive Radiotherapy of Anal Cancer | NCT05438836 | Anal Cancer Anal Carcinoma Anal Squamous C... | online adaptive... | 18 Years - | Herlev Hospital | |
| Hybrid Capture 2 Human Papiloma Virus (HPV) High-Risk Anal DNA Test | NCT01104181 | Anal Canal HPV ... Anal Dysplasia ... Anal Cancer | HC2 collection ... | 18 Years - 90 Years | Laser Surgery Care | |
| Patient Reported Outcomes (PROs) in Anal Cancer Patient Treated by Intensity Modulated Radiotherapy (IMRT). | NCT06364579 | Anal Cancer Pat... | 18 Years - | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | ||
| A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors | NCT03517488 | Melanoma Breast Carcinom... Hepatocellular ... Urothelial Carc... Squamous Cell C... Renal Cell Carc... Colorectal Carc... Non-small Cell ... Gastric or Gast... Endometrial Car... Mesothelioma Neuroendocrine ... Cervical Cancer Small Cell Lung... Squamous Cell C... Castration-Resi... Nasopharyngeal ... Cholangiocarcin... Basal Cell Carc... Ovarian Carcino... Fallopian Tube ... Thymoma Thymic Carcinom... Squamous Cell C... Vulvar Carcinom... Solid Tumors Wi... Malignant Adnex... Non-squamous Ce... | XmAb20717 | 18 Years - | Xencor, Inc. | |
| Interleukin-12 in Treating Patients With Cancer in the Abdomen | NCT00003046 | Anal Cancer Colorectal Canc... Gallbladder Can... Gastric Cancer Pancreatic Canc... | Recombinant Int... | 18 Years - | M.D. Anderson Cancer Center | |
| Role of Antisecretory Factor in Curative Radiochemotherapy for Anal Carcinoma | NCT05351931 | Anal Cancer | Salovum and SPC... | 18 Years - | Uppsala University Hospital | |
| T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers | NCT02280811 | Vaginal Cancer Cervical Cancer Anal Cancer Penile Cancer Oropharyngeal C... | Fludarabine Cyclophosphamid... E6 TCR Aldesleukin | 18 Years - 70 Years | National Institutes of Health Clinical Center (CC) | |
| Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection | NCT03677960 | HSIL, High-Grad... Human Papilloma... HIV Infection Anal Cancer Anus Neoplasm | Topical ABI-196... | 27 Years - | Antiva Biosciences | |
| Radiation Therapy, Cisplatin, Fluorouracil, and Cetuximab in Treating Patients With Locally Advanced Anal Cancer | NCT00955240 | Anal Cancer | cetuximab cisplatin fluorouracil laboratory biom... radiation thera... | 18 Years - 80 Years | UNICANCER | |
| Phase 1 Study of Oral TP-1454 | NCT04328740 | Advanced Solid ... Anal Cancer | TP-1454 monothe... | 18 Years - | Sumitomo Pharma America, Inc. | |
| Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2). | NCT04472429 | Squamous Cell C... | carboplatin paclitaxel retifanlimab | 18 Years - | Incyte Corporation | |
| Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer | NCT00003427 | Anal Cancer Colorectal Canc... Esophageal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Gastrointestina... Liver Cancer Pancreatic Canc... Small Intestine... | irinotecan hydr... oxaliplatin | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers | NCT05686226 | Cervical Cancer Throat Cancer Oropharynx Canc... Anal Cancer Vulva Cancer Vaginal Cancer Penile Cancer Metastatic Canc... HPV-Related Mal... HPV-Related Car... HPV-Related Cer... HPV-Related Squ... HPV-Related Ade... HPV Positive Or... HPV-Associated ... HPV-Related Ade... HPV-Related End... HPV-Related Ana... HPV-Related Pen... HPV-Related Vul... HPV Positive Re... | E7 TCR-T cells | 18 Years - | Rutgers, The State University of New Jersey | |
| Phase I Study of Cetuximab in Combination With 5-fluoruracil, Mitomycin C and Radiotherapy in Patients With Anal Cancer Stage T2 (>4 cm) - T4 N0-3 M0 or Any T N2-3 M0 | NCT01621217 | Locally Advance... | Cetuximab Mitomycin C 5-Fluoruracil Radiotherapy | 18 Years - | Lund University Hospital | |
| Anal Cancer Risk In Women | NCT05835947 | Anal Cancer Human Papilloma... Anal Intraepith... Genital Neoplas... Genital Cancer | Dual Pathology | 25 Years - 100 Years | Imperial College London | |
| Re-optimization Based Online Adaptive Radiotherapy of Anal Cancer | NCT05438836 | Anal Cancer Anal Carcinoma Anal Squamous C... | online adaptive... | 18 Years - | Herlev Hospital | |
| CRTE7A2-01 TCR-T Cells for HPV-16 Positive Advanced Cancers | NCT06358053 | Cervical Cancer Anal Cancer Head and Neck C... Other Solid Tum... | CRTE7A2-01 TCR-... | 18 Years - 65 Years | Corregene Biotechnology Co., Ltd | |
| Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma Patients | NCT02526953 | Anus Neoplasms Carcinoma, Squa... Anus Diseases Neoplasms Neoplasms, Squa... Carcinoma | Paclitaxel Capecitabine Capecitabine Mitomycins Mitomycins Radiotherapy | 18 Years - 70 Years | Blokhin's Russian Cancer Research Center | |
| Circulating Biomarkers in Patients With Anal Cancer Treated With Induction Chemotherapy | NCT05233540 | Anal Cancer Locally Advance... Oligometastatic... Circulating Tum... Human Papilloma... | 18 Years - | Aarhus University Hospital | ||
| A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers | NCT04708470 | Oropharyngeal C... Neck Cancer Human Papilloma... HPV Anal Cancer Cervical Cancer Penile Cancer Vulvar Cancer Vaginal Cancer Colon Cancer | Bintrafusp Alfa NHS-IL12 Entinostat | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | |
| Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent Tumors | NCT04889742 | Recurrent Cance... Prostate Cancer Cervical Cancer Anal Cancer Sarcoma Rectal Cancer Neuroendocrine ... Esophageal Canc... Pancreas Cancer Squamous Cell C... | loco-regional h... | 18 Years - | Charite University, Berlin, Germany | |
| A Study Regarding Tissue Response During and After Treatment for Anal Cancer | NCT05939401 | Anal Cancer | Biopsies | 18 Years - | Sahlgrenska University Hospital, Sweden | |
| A Study of Safety and Efficacy of KFA115 Alone and in Combination With Pembrolizumab in Patients With Select Advanced Cancers | NCT05544929 | Carcinoma, Non-... Cutaneous Melan... Carcinoma, Rena... Carcinoma, Ovar... Nasopharyngeal ... Carcinoma, Thym... Anal Cancer Mesothelioma Esophagogastric... High Microsatel... Squamous Cell C... Triple Negative... | KFA115 pembrolizumab | 18 Years - | Novartis | |
| A Safety and Efficacy Trial of Circumferential Anal Canal Radiofrequency Ablation for High-Grade Anal Intraepithelial Neoplasia Using the BARRX™ Anorectal Wand | NCT03302858 | HSIL, High Grad... Anal Cancer HPV-Related Squ... Human Papilloma... Human Papilloma... Ain III | BARRX™ Anorecta... | 18 Years - 75 Years | Laser Surgery Care | |
| Patient Reported Outcomes (PROs) in Anal Cancer Patient Treated by Intensity Modulated Radiotherapy (IMRT). | NCT06364579 | Anal Cancer Pat... | 18 Years - | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | ||
| Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer | NCT00423293 | Anal Cancer | fluorouracil mitomycin C Intensity-modul... | 18 Years - 120 Years | Radiation Therapy Oncology Group | |
| Pencil Beam Proton Therapy for Recurrences in Anal Cancer Patients Previously Treated With Radiotherapy (DACG 5) | NCT05055635 | Anal Cancer Recurrent Anal ... | Pencil beam pro... | 18 Years - | University of Aarhus | |
| Assessing Drivers and Barriers to Follow-Up Screening for Anal Cancer in Men Who Have Sex With Men | NCT00501306 | Anal Cancer | 18 Years - 85 Years | Laser Surgery Care | ||
| Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer | NCT00324415 | Anal Cancer | cetuximab cisplatin fluorouracil radiation thera... | 18 Years - 120 Years | AIDS Malignancy Consortium | |
| A Phase 2 Study of Axalimogene Filolisbac (ADXS11-001) in Participants With Carcinoma of the Anorectal Canal | NCT02399813 | Anal Cancer Rectal Cancer | Axalimogene fil... | 18 Years - | Advaxis, Inc. | |
| EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer. | NCT06263088 | Gastrointestina... Colon Cancer Rectal Cancer Anal Cancer Esophageal Canc... Stomach Cancer Appendix Cancer Pancreas Cancer Liver Cancer Neuroendocrine ... | EQUITY GI | 18 Years - | Case Comprehensive Cancer Center | |
| A Prospective, Open-Label, Multi-center Comparison of Lymphoseek Identified Lymph Nodes and Clinically Identified Lymph Nodes of Subjects With Known Cancer of the Anus | NCT02857608 | Anal Cancer | Lymphoseek | 18 Years - | Cardinal Health 414, LLC | |
| RTX-321 Monotherapy in Patients With HPV 16+ Tumors | NCT04672980 | Cervical Cancer Head and Neck C... Anal Cancer | RTX-321 | 18 Years - | Rubius Therapeutics | |
| Radiation Therapy, Cisplatin, Fluorouracil, and Cetuximab in Treating Patients With Locally Advanced Anal Cancer | NCT00955240 | Anal Cancer | cetuximab cisplatin fluorouracil laboratory biom... radiation thera... | 18 Years - 80 Years | UNICANCER | |
| Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy | NCT00896467 | Anal Cancer Anxiety Disorde... Breast Cancer Depression Esophageal Canc... Gallbladder Can... Gastric Cancer Kidney Cancer Liver Cancer Lung Cancer Pancreatic Canc... Small Intestine... | questionnaire a... psychosocial as... quality-of-life... | 18 Years - | National Cancer Institute (NCI) | |
| Anal Cancer Radiotherapy Study | NCT01937780 | Anal Cancer | 18 Years - | Oslo University Hospital | ||
| Prospective Cohort on Quality of Sexual Life Among Men Who Have Sex With Men Treated for Anal Cancer With Concurrent Chemotherapy and Intensity-modulated Radiotherapy | NCT02949596 | Anal Cancer Quality of Life | Quality of life... | - | Instituto do Cancer do Estado de São Paulo | |
| A Study of mDCF in Combination or Not With Atezolizumab in Advanced Squamous Cell Anal Carcinoma | NCT03519295 | Anal Cancer | MPDL3280A mDCF | 18 Years - | GERCOR - Multidisciplinary Oncology Cooperative Group | |
| Phase 1 Study of Oral TP-1454 | NCT04328740 | Advanced Solid ... Anal Cancer | TP-1454 monothe... | 18 Years - | Sumitomo Pharma America, Inc. | |
| Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males | NCT01209325 | Anal Cancer Nonneoplastic C... Penile Cancer Precancerous Co... | quadrivalent hu... laboratory biom... | 13 Years - 26 Years | AIDS Malignancy Consortium | |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer | NCT00003652 | Anal Cancer | cisplatin fluorouracil neoadjuvant the... radiation thera... | 0 Years - 80 Years | UNICANCER | |
| Molecular Biology of Anal Cancer in HIV-Positive Patients | NCT00952874 | Carcinoma HIV Infections | 20 Years - 80 Years | University Hospital, Geneva | ||
| International Multicentre Study in Advanced Anal Cancer Comparing Cisplatin Plus 5 FU vs Carboplatin Plus Weekly Paclitaxel | NCT02051868 | Squamous Cell C... | Cisplatin 5-Fluorouracil ... Carboplatin Paclitaxel | 18 Years - | Royal Marsden NHS Foundation Trust | |
| Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors | NCT00028405 | Liver Metastasi... Pelvic Cancer Head and Neck C... Sarcoma Rectal Cancer Breast Cancer Colorectal Canc... Mouth Cancer | LS 11(Taporfin ... Lumaflex Light ... | 18 Years - | Light Sciences LLC | |
| Image Fusion PET, CT and 3D-ultrasound Examinations | NCT00302094 | Anal Cancer | 18 Years - | Rigshospitalet, Denmark | ||
| Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003) | NCT01651949 | Genital Warts Anal Cancer Anal Intraepith... | 9vHPV Vaccine | 16 Years - 26 Years | Merck Sharp & Dohme LLC | |
| Circulating Biomarkers in Patients With Anal Cancer Treated With Induction Chemotherapy | NCT05233540 | Anal Cancer Locally Advance... Oligometastatic... Circulating Tum... Human Papilloma... | 18 Years - | Aarhus University Hospital | ||
| A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors | NCT05551117 | Castration-Resi... Androgen-Indepe... Androgen-Insens... Androgen-Resist... Hormone Refract... Anal Cancer Anal Neoplasm Carcinoma, Squa... Head and Neck S... Laryngeal Squam... Oral Squamous C... Malignant Melan... Melanoma Non-small Cell ... Non-small Cell ... Small-cell Lung... Small Cell Carc... | vobramitamab du... vobramitamab du... vobramitamab du... | 18 Years - | MacroGenics | |
| A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers | NCT04708470 | Oropharyngeal C... Neck Cancer Human Papilloma... HPV Anal Cancer Cervical Cancer Penile Cancer Vulvar Cancer Vaginal Cancer Colon Cancer | Bintrafusp Alfa NHS-IL12 Entinostat | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | |
| Prospective Observational Trial to Evaluate Quality of Life After Definitive Chemoradiation in Patients With Anal Cancer (LANACARE) | NCT03792854 | Anal Cancer Quality of Life Chemoradiation | EORTC QLQ C30 EORTC QLQ CR29 | 18 Years - | Ludwig-Maximilians - University of Munich | |
| Open Pilot Trial of a Mind-Body Sexual Well-Being Intervention for Female GI Cancer Survivors | NCT06331403 | Colorectal Canc... Anal Cancer Sexual Dysfunct... | Mind-Body Group... | 18 Years - | Massachusetts General Hospital | |
| SGN-00101 in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia | NCT00052897 | Anal Cancer | HspE7 | 18 Years - | National Cancer Institute (NCI) | |
| Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003) | NCT01651949 | Genital Warts Anal Cancer Anal Intraepith... | 9vHPV Vaccine | 16 Years - 26 Years | Merck Sharp & Dohme LLC | |
| Pembrolizumab in Metastatic Anal Cancer | NCT02919969 | Anal Cancer | Pembrolizumab | 18 Years - | Dana-Farber Cancer Institute | |
| Early Rectal Cancer: Endoscopic Submucosal Dissection or Transanal Endoscopic Microsurgery? | NCT02885142 | Anal Cancer | Local excision ... | 18 Years - | Assistance Publique Hopitaux De Marseille | |
| Proton Therapy in Reducing Toxicity in Anal Cancer | NCT03018418 | Anus Neoplasms | Proton therapy Chemotherapy | 18 Years - | University of Cincinnati | |
| Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer. | NCT03061435 | Vulvar Cancer Cervical Cancer Vulvar Dysplasi... Cervical Dyspla... Anal Cancer Anal Dysplasia HPV-Related Ana... | Screening anal ... Screening anal ... | 40 Years - | Sunnybrook Health Sciences Centre | |
| Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2). | NCT04472429 | Squamous Cell C... | carboplatin paclitaxel retifanlimab | 18 Years - | Incyte Corporation | |
| Identification of Predictive Factors for Physiological Hypermetabolism of the Anal Canal in 18F-FDG PET / CT | NCT03506529 | Anal Cancer | questionnary | 18 Years - | Centre Francois Baclesse | |
| Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer | NCT00003596 | Anal Cancer | cisplatin fluorouracil mitomycin C radiation thera... | 18 Years - 120 Years | Radiation Therapy Oncology Group | |
| Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma. A Multicenter, Randomized, Phase II Trial of the German Anal Cancer Study Group | NCT04230759 | Anal Cancer Anal Carcinoma Anal Cancer Sta... Anal Cancer Sta... | Chemotherapy Radiation Durvalumab | 18 Years - | Goethe University | |
| Study of IMRT Radiotherapy Concurrent Chemothrerapy for Anal Cancer | NCT03381352 | Anal Cancer | Chemo-radiother... Capecitabine Mitomycin C | 18 Years - 70 Years | ChineseAMS | |
| Radiation Therapy, Cisplatin, Fluorouracil, and Cetuximab in Treating Patients With Locally Advanced Anal Cancer | NCT00955240 | Anal Cancer | cetuximab cisplatin fluorouracil laboratory biom... radiation thera... | 18 Years - 80 Years | UNICANCER | |
| A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccine | NCT05694728 | Human Papilloma... | Recombinant Non... Recombinant Qua... | 20 Years - 45 Years | Beijing Health Guard Biotechnology, Inc | |
| Deciphering Mechanisms Underlying Cancer Immunogenicity | NCT03958240 | Head and Neck C... Ovarian Cancer Cervical Cancer Cervical Intrae... Glioblastoma Mu... Non Small Cell ... Anal Cancer | Blood samples, ... | 18 Years - | Institut Claudius Regaud | |
| Assessment of Patients' Quality of Sexual Life After Anal Cancer Treatment | NCT05109468 | Anal Cancer Sexuality Psychologic Str... HPV Anxiety | Quality of life... | 18 Years - | Institut du Cancer de Montpellier - Val d'Aurelle | |
| Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors | NCT05858736 | Melanoma Non Small Cell ... Head and Neck S... High Grade Sero... Primary Periton... Fallopian Tube ... Endometrial Can... Cervical Cancer Renal Cell Carc... Bladder Cancer Esophageal Canc... Gastric Cancer Gastroesophagea... Colorectal Canc... Anal Cancer Hepatocellular ... Bile Duct Cance... | AI-061 | 18 Years - | OncoC4, Inc. | |
| A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation | NCT04141449 | Neoplasms Hiv Cervical Cancer Breast Cancer HNSCC Vulvar Cancer Anal Cancer Cancer Suspect | Potlako interve... Enhanced care | 30 Years - | Brigham and Women's Hospital | |
| Study of Vaginal Dilator Use After Pelvic Radiotherapy | NCT00789893 | Cervical Cancer Endometrial Can... Rectal Cancer Anal Cancer | Vaginal Dilator | 21 Years - 85 Years | Memorial Sloan Kettering Cancer Center | |
| Screening Women With Prior HPV for Anal Neoplasia | NCT05217940 | HPV-related Low... HPV-related Ana... Early Stage Low... | Diagnostic test... | 35 Years - | Icahn School of Medicine at Mount Sinai | |
| Infrared Coagulator Ablation or Observation in Preventing Anal Cancer in HIV-Positive Patients With Anal Neoplasia | NCT01164722 | Anal Cancer Neoplasm of Unc... Nonneoplastic C... Precancerous Co... | clinical observ... infrared photoc... | 27 Years - | AIDS Malignancy Consortium | |
| Integrating a Health Information Technology System for Primary and Secondary Cervical Cancer Prevention | NCT03346915 | Human Papilloma... Cervical Cancer Human Papilloma... Oropharyngeal C... Vaginal Cancer Vulvar Cancer Anal Cancer Penile Cancer | WoW and BNI | 9 Years - 65 Years | Boston Medical Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
